Rankings
▼
Calendar
TEVA Q3 2018 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$36B
Q3 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.5B
-19.3% YoY
Gross Profit
$2.0B
44.6% margin
Operating Income
$16M
0.4% margin
Net Income
-$208M
-4.6% margin
EPS (Diluted)
$-0.20
QoQ Revenue Growth
-3.7%
Cash Flow
Operating Cash Flow
$421M
Free Cash Flow
$282M
Stock-Based Comp.
$45M
Balance Sheet
Total Assets
$65.1B
Total Liabilities
$45.9B
Stockholders' Equity
$17.7B
Cash & Equivalents
$1.9B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.5B
$5.6B
-19.3%
Gross Profit
$2.0B
$2.6B
-23.5%
Operating Income
$16M
$378M
-95.8%
Net Income
-$208M
$530M
-139.2%
Revenue Segments
International Markets
$498M
100%
Geographic Segments
North America
$1.9B
61%
Europe
$1.2B
39%
← FY 2018
All Quarters
Q4 2018 →